Diagnostic Testing & Technology Report
September 2008
Rosetta Genomics Completes Purchase of Parkway Clinical Labs
On July 24, microRNA (miRNA)-focused Rosetta Genomics (Rehovot, Israel, and Jersey City, N.J.) completed its acquisition of Parkway Clinical Laboratories (Bensalem, Penn.) for $2.9 million in cash and stock, with an additional payment to be triggered by the achievement of certain milestones.
Login | Subscribe
September 2008 - Table of Contents
Diagnostic Testing & Technology Report is part of...
Focus Areas |
Product Group |
 G2 Reports Medical Lab Management |
Newsletters |